Delayed Graft Function Clinical Trials

50 clinical trials for Delayed Graft Function across international registries, including 3 currently recruiting participants. Compare status, phase, eligibility criteria and locations.

• Double-blind, Randomized, Placebo-controlled, Multicenter Study to Evaluate the Efficacy and Safety of Ravulizumab Administered Intravenously in Adult Participants at High Risk of Delayed Graft Function After Kidney Transplantation — RECRUITING · PHASE3
• Safety and Efficacy of Treprostinil (Remodulin®) In Reducing Ischemia-Reperfusion Injury During Kidney Transplantation — RECRUITING · PHASE1
• The Effects of Vonoprazan Fumarate on DGF Incidence in DD Kidney Transplant Recipients — RECRUITING · PHASE1
• Study of Eculizumab in Adult Subjects at Risk for Developing Delayed Graft Function. — COMPLETED · PHASE3
• Furosemide Stress Test Predicting Early Graft Function in Kidney Transplantation — COMPLETED · NA
• The Impact of Intraoperative Diuretic Use on Delayed Graft Function Following Deceased Donor Renal Transplantation — NOT_YET_RECRUITING · NA
• Effect of Terlipressin for Intraoperative Blood Pressure Management in Kidney Transplantation — ACTIVE_NOT_RECRUITING · NA
• Study to Evaluate the Efficacy and Safety of Pegcetacoplan in Adults at High Risk of Delayed Graft Function (DGF) Following Kidney Allograft Transplantation — SUSPENDED · PHASE3
• ARGX-117 in Deceased Donor Kidney Transplant Recipients at Risk for Delayed Graft Function — ACTIVE_NOT_RECRUITING · PHASE2
• Volatile Anesthetic Protection Of Renal Transplants 2 — COMPLETED · PHASE4
• Study of the Correlation Between Donor CIRBP and Transplanted Kidney Function — COMPLETED
• Better Evidence for Selecting Transplant Fluids — COMPLETED · PHASE3
• Graft Acute Kidney Injury: Vitamin B3 to Facilitate Renal Recovery In the Early Life of a Transplant — COMPLETED · PHASE3
• Intermittent Versus Continuous Surface O2 During HMP of DCD Kidneys — OTHER · PHASE3
• Norepinephrine Infusion Combined With Goal-directed Fluid Therapy in Patients Undergoing Kidney Transplantations — OTHER · NA
• Envarsus in Delayed Graft Function (E-DGF) — COMPLETED · PHASE4
• Novel Cooling Device for the Elimination of Warm Ischemia During Renal Transplantation — OTHER · NA
• Deceased Organ Donor Interventions to Protect Kidney Graft Function — COMPLETED · NA
• Tacrolimus to Sirolimus Conversion for Delayed Graft Function — TERMINATED · PHASE4
• Belatacept for Renal Transplant Recipients With Delayed Graft Function — TERMINATED · PHASE1
• Reduce the Severity of DGF in Recipients of a Deceased Donor Kidney — OTHER · PHASE3
• Renaparin® in Kidney Transplantation — COMPLETED · PHASE1
• QPI-1002 for Prevention of Delayed Graft Function in Recipients of an Older Donor Kidney Transplant — COMPLETED · PHASE3
• Propensity Score Matched Comparison of HMP vs. SCS in Kidney Transplantation — COMPLETED
• Deceased Donor Biomarkers and Recipient Outcomes — COMPLETED
• Evaluation of CAF22 After Renal Transplantation — COMPLETED
• A Pilot Study Comparing the Safety and Efficacy of Everolimus With Other Medicines in Recipients of ECD/DCD Kidneys — TERMINATED · PHASE2
• Prevention of Delayed Graft Function Using Eculizumab Therapy (PROTECT Study) — COMPLETED · PHASE2
• C1INH Inhibitor Preoperative and Post Kidney Transplant to Prevent DGF & IRI — COMPLETED · PHASE1
• The Frequency and Risk Factors of Delayed Graft Function — COMPLETED
• Intra-graft Coagulation Events in Clinical Renal Transplantation and Delayed Graft Function — OTHER
• Eculizumab for Prevention of Delayed Graft Function (DGF) in Kidney Transplantation — TERMINATED · PHASE2
• Placebo-Controlled Study to Evaluate the Safety and Efficacy of OPN-305 in Preventing Delayed Renal Graft Function — COMPLETED · PHASE2
• Early Conversion From CNI to Belatacept in Renal Transplant Recipients With Delayed and Slow Graft Function — OTHER · PHASE2
• A Study of Retrograde rEperfusion in Dbd Donor LIver Transplantation — OTHER · NA
• Delayed Renal Allograft Function and Furosemide Treatment — WITHDRAWN · PHASE2
• CliniMACS® CD34+ Reagent System for Expanded Access Use — TERMINATED
• Comparison of Sirolimus and Azathioprine in Lung Transplantation — COMPLETED · PHASE4
• Role of T Helper 17 and Regulatory T Cells in Delayed Graft Function — OTHER
• Prediction and Management of Delayed Graft Function Based on Donor Criteria and LifePort Platform — OTHER
• Correlation of Molecular Biomarkers With Biopsy Findings and Outcomes in Renal Transplant Recipients — COMPLETED
• Biomarkers of Aging as Predictors of Kidney Transplant Function — COMPLETED
• Study on Delayed Graft Function Using Paired Kidneys — OTHER · PHASE2
• Can Fat Derived Stem Cells (SVF) be Used in the Treatment of Erectile Dysfunction After Prostatectomy — OTHER · PHASE1
• Context - Remote Ischemic Conditioning in Renal Transplantation - Effect on Immediate and Extended Kidney Graft Function — OTHER · NA
• Study to Improve Renal Function After Kidney Transplantation — OTHER · PHASE2
• I5NP for Prophylaxis of Delayed Graft Function in Kidney Transplantation — COMPLETED · PHASE1
• A Kidney Transplant Study to Look at the Effects of Taking Fixed Doses of CellCept Versus Taking Doses of CellCept Based on the Concentration of CellCept in the Blood When Taking Full or Reduced Dose Calcineurin Inhibitors — TERMINATED · PHASE4
• Effect of Procrit (Epoetin Alfa) on Preventing Delayed Graft Function After Deceased Donor Renal Transplantation — COMPLETED · PHASE4
• YSPSL for Prevention of Delayed Graft Function Part A — COMPLETED

Refine this search